German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and tolerability of treatment for T-lymphoblastic lymphoma
(T-LBL) according to a protocol for acute lymphoblastic leukemia. Patients receive one year
of intensive cyclical chemotherapy with additional prophylaxis for central nervous system
(CNS) relapse by intrathecal therapy and cranial irradiation and mediastinal irradiation
after induction chemotherapy.